# OR52A1

## Overview
OR52A1 is a gene that encodes the protein olfactory receptor family 52 subfamily A member 1, which belongs to the G-protein-coupled receptor (GPCR) superfamily. These receptors are integral membrane proteins that play a crucial role in the detection of odorants and the initiation of olfactory signal transduction pathways, ultimately contributing to the sense of smell. OR52A1 is primarily expressed in the olfactory epithelium, where it binds specific odor molecules, but it is also found in non-olfactory tissues, suggesting potential roles beyond traditional sensory functions (Foster2014Extrasensory; Van2011Homozygous). The gene has been implicated in various clinical contexts, including beta-thalassemia and cancer, highlighting its significance in both sensory and non-sensory biological processes (Oh2024Genomic; Van2011Homozygous).

## Function
OR52A1 is a gene that encodes an olfactory receptor protein, which is part of the G-protein-coupled receptor (GPCR) family. These receptors are primarily involved in detecting odor molecules and initiating a signal transduction pathway that results in the perception of smell. OR52A1 is expressed in the olfactory epithelium, where it binds specific odorants, triggering neuronal responses that contribute to the sense of smell (Van2011Homozygous).

Beyond its role in olfaction, OR52A1 has been identified in non-olfactory tissues, such as human erythroid cells, where its function is less understood (Foster2014Extrasensory). The receptor's expression in these cells suggests potential roles beyond traditional sensory functions, although specific molecular processes and organismal outcomes in these contexts remain to be fully elucidated (Foster2014Extrasensory).

In individuals with beta-thalassemia, a homozygous deletion of OR52A1, along with other olfactory receptor genes, has been associated with altered olfactory abilities and potentially exacerbated anemia due to the loss of a c-globin enhancer element linked to OR52A1. This enhancer is important for the continuous expression of fetal c-globin genes, which help alleviate anemia by increasing hemoglobin F production (Van2011Homozygous).

## Clinical Significance
The OR52A1 gene has been implicated in several clinical contexts, particularly in relation to beta-thalassemia and cancer. In individuals with beta-thalassemia, a homozygous deletion affecting OR52A1 and other olfactory receptor genes has been observed. This deletion includes a c-globin enhancer element, which is crucial for the expression of fetal c-globin genes. The absence of this enhancer may lead to reduced compensatory c-globin expression, potentially exacerbating anemia in these individuals (Van2011Homozygous).

In the context of cancer, OR52A1 expression has been studied in gastric cancer with bone metastasis. It was found that OR52A1 expression is significantly reduced in patients with bone metastasis compared to those without, suggesting a potential role in the progression or severity of the disease (Oh2024Genomic).

Additionally, in retinoblastoma, a study identified lnc-OR52A1-55, a long noncoding RNA associated with OR52A1, as being overexpressed in retinoblastoma cells, indicating a possible involvement in the disease's molecular mechanisms (Feng2021Identification).


## References


[1. (Feng2021Identification) Xiaofen Feng, Jian Gong, Qian Li, Chao Xing, Jiandong Pan, Ruitao Zou, Liya Zheng, and Feng Chen. Identification and functional annotation of differentially expressed long noncoding rnas in retinoblastoma. Experimental and Therapeutic Medicine, October 2021. URL: http://dx.doi.org/10.3892/etm.2021.10882, doi:10.3892/etm.2021.10882. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/etm.2021.10882)

[2. (Oh2024Genomic) Sujin Oh, Soo Kyung Nam, Keun-Wook Lee, Hye Seung Lee, Yujun Park, Yoonjin Kwak, Kyu Sang Lee, Ji-Won Kim, Jin Won Kim, Minsu Kang, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, and Hyung Ho Kim. Genomic and transcriptomic characterization of gastric cancer with bone metastasis. Cancer Research and Treatment, 56(1):219–237, January 2024. URL: http://dx.doi.org/10.4143/crt.2023.340, doi:10.4143/crt.2023.340. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.4143/crt.2023.340)

[3. (Foster2014Extrasensory) Simon R. Foster, Eugeni Roura, and Walter G. Thomas. Extrasensory perception: odorant and taste receptors beyond the nose and mouth. Pharmacology &amp; Therapeutics, 142(1):41–61, April 2014. URL: http://dx.doi.org/10.1016/j.pharmthera.2013.11.004, doi:10.1016/j.pharmthera.2013.11.004. This article has 99 citations.](https://doi.org/10.1016/j.pharmthera.2013.11.004)

[4. (Van2011Homozygous) Jessica Van Ziffle, Wendy Yang, and Farid F. Chehab. Homozygous deletion of six olfactory receptor genes in a subset of individuals with beta-thalassemia. PLoS ONE, 6(2):e17327, February 2011. URL: http://dx.doi.org/10.1371/journal.pone.0017327, doi:10.1371/journal.pone.0017327. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0017327)